The median value of CRMP1 mRNA expression was used to classify patients into high or low expression groups, whereby patients with low CRMP1 expression were found to exhibit a more advanced level of disease and lymph node metastasis. The gene discussed is CRMP1; the disease is metastatic malignant neoplasm in the lymph nodes.